Crexendo (CXDO) COO: 278 and 277 RSUs vested on Oct 25

Crexendo (CXDO) Chief Operating Officer Douglas Walter Gaylor filed a Form 4 reporting routine equity vesting on 10/25/2025.

Rhea-AI Filing Summary

Crexendo (CXDO) Chief Operating Officer Douglas Walter Gaylor filed a Form 4 reporting routine equity vesting on 10/25/2025. Two tranches of RSUs converted to common stock: 278 shares and 277 shares at an exercise price of $0, reflecting delivery upon vesting.

To cover payroll taxes, the company withheld 76 shares for each vesting using the $6.40 closing price on October 25, 2025; the filing notes this does not represent a sale by the reporting person. Following these transactions, Gaylor held 243,135 shares directly.

The RSUs tied to 278 shares vest monthly over 36 months starting March 25, 2025, and the 277-share grant vests monthly over 36 months starting October 25, 2025, each subject to continuous employment.

Insider Trade Summary

555 shares exercised/converted

Exercise 6 txns

Insider Gaylor Douglas Walter

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	278	$0.00	$0.00
Exercise	Restricted Stock Units	277	$0.00	$0.00
Exercise	Common Stock	278	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	76	$6.40	$486.40
Exercise	Common Stock	277	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	76	$6.40	$486.40

Holdings After Transaction: Restricted Stock Units — 17,502 contracts (Direct); Common Stock — 243,135 shares (Direct)

Footnotes (4)

1. F1. Each RSU represents the right to receive, upon vesting, one share of CXDO common stock contingent on continued employment.
2. F2. The Company withheld 76 shares of common stock for payment of the associated payroll taxes, using the closing stock price on October 25, 2025 of $6.40. This transaction does not represent a sale by the reporting person.
3. F3. The RSUs vest in equal monthly installments over 36 months starting on March 25, 2025 until such time as the RSUs are 100% vested, subject to continuous employment. Shares will be delivered upon vesting.
4. F4. The RSUs vest in equal monthly installments over 36 months starting on October 25, 2025 until such time as the RSUs are 100% vested, subject to continuous employment. Shares will be delivered upon vesting.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Crexendo (CXDO) report in this Form 4?

The COO reported two RSU vestings converting to common stock on 10/25/2025, with related tax share withholdings.

How many RSUs vested for the Crexendo COO on 10/25/2025?

Two tranches vested: 278 shares and 277 shares, each delivered at an exercise price of $0.

Were any shares sold by the reporting person?

No. The filing states the 76-share withholdings per tranche were for taxes at $6.40 and do not represent a sale.

What is the COO’s direct share ownership after these transactions?

Direct beneficial ownership is 243,135 shares following the reported transactions.

What are the vesting schedules for these RSU awards?

The 278-share RSUs vest monthly over 36 months from March 25, 2025; the 277-share RSUs vest monthly over 36 months from October 25, 2025.

What price was used for tax withholding on the vest date?

The company used the $6.40 closing price on October 25, 2025 to calculate tax withholdings of 76 shares per tranche.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 02:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gaylor Douglas Walter

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/25/2025		M		278	A	$0(1)	243,010	D
Common Stock	10/25/2025		F(2)		76	D	$6.4	242,934	D
Common Stock	10/25/2025		M		277	A	$0(1)	243,211	D
Common Stock	10/25/2025		F(2)		76	D	$6.4	243,135	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(1)	10/25/2025		M			278	(3)	(3)	Common Stock	278	$0	7,779	D
Restricted Stock Units	$0(1)	10/25/2025		M			277	(4)	(4)	Common Stock	277	$0	9,723	D

Explanation of Responses:

1. Each RSU represents the right to receive, upon vesting, one share of CXDO common stock contingent on continued employment.

2. The Company withheld 76 shares of common stock for payment of the associated payroll taxes, using the closing stock price on October 25, 2025 of $6.40. This transaction does not represent a sale by the reporting person.

3. The RSUs vest in equal monthly installments over 36 months starting on March 25, 2025 until such time as the RSUs are 100% vested, subject to continuous employment. Shares will be delivered upon vesting.

4. The RSUs vest in equal monthly installments over 36 months starting on October 25, 2025 until such time as the RSUs are 100% vested, subject to continuous employment. Shares will be delivered upon vesting.

	/s/Douglas Walter Gaylor	10/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.